针对复发根源：消除抗治疗性乳腺癌干细胞的新策略。
Targeting the Roots of Recurrence: New Strategies for Eliminating Therapy-Resistant Breast Cancer Stem Cells.
作者信息
Dahn Margaret L, Marcato Paola
机构信息
Department of Pathology, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Department of Microbiology and Immunology, Dalhousie University, Halifax, NS B3H 4R2, Canada.
出版信息
Cancers (Basel). 2020 Dec 28;13(1):54. doi: 10.3390/cancers13010054.
Abstract
Cancer stem cells (CSCs) are functionally defined in our laboratories by their impressive tumor-generating and self-renewal capacity; clinically, CSCs are of interest because of their enhanced capacity to evade conventional therapies [...].
摘要
癌症干细胞（CSCs）在我们实验室中的功能定义是其具有显著的肿瘤生成和自我更新能力；在临床上，CSCs备受关注是因为它们逃避传统疗法的能力增强了[……]
相似文献
1
Targeting the Roots of Recurrence: New Strategies for Eliminating Therapy-Resistant Breast Cancer Stem Cells.
Cancers (Basel). 2020 Dec 28;13(1):54. doi: 10.3390/cancers13010054.
2
Cervical cancer stem cells: opportunities and challenges.
J Cancer Res Clin Oncol. 2015 Nov;141(11):1889-97. doi: 10.1007/s00432-014-1905-y. Epub 2015 Jan 7.
3
[The role of cancer stem cells in progressive growth and resistance of ovarian cancer: true or fiction?].
Postepy Hig Med Dosw (Online). 2015 Sep 20;69:1077-86.
4
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.
Cancers (Basel). 2019 Oct 15;11(10):1569. doi: 10.3390/cancers11101569.
5
Cancer stem cells as a potential therapeutic target in breast cancer.
Stem Cell Investig. 2014 Jul 16;1:14. doi: 10.3978/j.issn.2306-9759.2014.06.01. eCollection 2014.
6
Breast cancer stem cells and the challenges of eradication: a review of novel therapies.
Stem Cell Investig. 2018 Oct 31;5:39. doi: 10.21037/sci.2018.10.05. eCollection 2018.
7
Combination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment.
Cancer Biol Ther. 2016 Jun 2;17(6):698-707. doi: 10.1080/15384047.2016.1190488.
8
Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells.
J Oncol. 2020 Mar 9;2020:3963561. doi: 10.1155/2020/3963561. eCollection 2020.
9
The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy.
Cancers (Basel). 2019 Jul 20;11(7):1021. doi: 10.3390/cancers11071021.
10
Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy.
Oncogenesis. 2015 Nov 30;4(11):e177. doi: 10.1038/oncsis.2015.35.
引用本文的文献
1
Mapping Knowledge Landscapes and Themes Trends of Breast Cancer Stem Cells: A Comprehensive Data-Mining-Based Study.
Ann Surg Oncol. 2025 Apr 23. doi: 10.1245/s10434-025-17336-3.
2
Biochemical implications of robotic surgery: a new frontier in the operating room.
J Robot Surg. 2024 Feb 24;18(1):91. doi: 10.1007/s11701-024-01861-6.
3
The application of nanoparticles in theranostic systems targeting breast cancer stem cells: current progress and future challenges.
Stem Cell Res Ther. 2023 Dec 10;14(1):356. doi: 10.1186/s13287-023-03584-1.
4
Alternative models of cancer stem cells: The stemness phenotype model, 10 years later.
World J Stem Cells. 2021 Jul 26;13(7):934-943. doi: 10.4252/wjsc.v13.i7.934.
本文引用的文献
1
The Missing Lnc: The Potential of Targeting Triple-Negative Breast Cancer and Cancer Stem Cells by Inhibiting Long Non-Coding RNAs.
Cells. 2020 Mar 20;9(3):763. doi: 10.3390/cells9030763.
2
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.
Cancers (Basel). 2019 Oct 15;11(10):1569. doi: 10.3390/cancers11101569.
3
Potential Role of MSC/Cancer Cell Fusion and EMT for Breast Cancer Stem Cell Formation.
Cancers (Basel). 2019 Sep 25;11(10):1432. doi: 10.3390/cancers11101432.
4
Early Steps of Mammary Stem Cell Transformation by Exogenous Signals; Effects of Bisphenol Endocrine Disrupting Chemicals and Bone Morphogenetic Proteins.
Cancers (Basel). 2019 Sep 12;11(9):1351. doi: 10.3390/cancers11091351.
5
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness.
Cancers (Basel). 2019 Sep 9;11(9):1334. doi: 10.3390/cancers11091334.
6
Role of the Microenvironment in Regulating Normal and Cancer Stem Cell Activity: Implications for Breast Cancer Progression and Therapy Response.
Cancers (Basel). 2019 Aug 24;11(9):1240. doi: 10.3390/cancers11091240.
7
SETDB-1: A Potential Epigenetic Regulator in Breast Cancer Metastasis.
Cancers (Basel). 2019 Aug 9;11(8):1143. doi: 10.3390/cancers11081143.
8
CSCs in Breast Cancer-One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs.
Cancers (Basel). 2019 Aug 7;11(8):1128. doi: 10.3390/cancers11081128.
9
Pivotal Role of AKT2 during Dynamic Phenotypic Change of Breast Cancer Stem Cells.
Cancers (Basel). 2019 Jul 26;11(8):1058. doi: 10.3390/cancers11081058.
10
The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer.
Cancers (Basel). 2019 Jul 22;11(7):1028. doi: 10.3390/cancers11071028.
Zotero 插件